206 related articles for article (PubMed ID: 36132131)
1. Biomarkers for risk-based treatment modifications for CNS germ cell tumors: Updates on biological underpinnings, clinical trials, and future directions.
Takami H; Ichimura K
Front Oncol; 2022; 12():982608. PubMed ID: 36132131
[TBL] [Abstract][Full Text] [Related]
2. 12p gain is predominantly observed in non-germinomatous germ cell tumors and identifies an unfavorable subgroup of central nervous system germ cell tumors.
Satomi K; Takami H; Fukushima S; Yamashita S; Matsushita Y; Nakazato Y; Suzuki T; Tanaka S; Mukasa A; Saito N; Kanamori M; Kumabe T; Tominaga T; Kobayashi K; Nagane M; Iuchi T; Yoshimoto K; Tamura K; Maehara T; Sakai K; Sugiyama K; Yokogami K; Takeshima H; Nonaka M; Asai A; Ushijima T; Matsutani M; Nishikawa R; Ichimura K
Neuro Oncol; 2022 May; 24(5):834-846. PubMed ID: 34698864
[TBL] [Abstract][Full Text] [Related]
3. [Molecular Characteristics and Clinical Significance of Germ Cell Tumors].
Takami H
No Shinkei Geka; 2023 Sep; 51(5):892-900. PubMed ID: 37743341
[TBL] [Abstract][Full Text] [Related]
4. PD-L1 and PD-1 expression in pediatric central nervous system germ cell tumors.
Woods JK; Lidov HG; Ligon KL; Santagata S; Chi SN; Yeo KK; Alexandrescu S
Mod Pathol; 2022 Dec; 35(12):1770-1774. PubMed ID: 36057740
[TBL] [Abstract][Full Text] [Related]
5. Brain and Spinal Tumors Originating from the Germ Line Cells.
Wong TT; Tsai ML; Chang H; Hsieh KL; Ho DM; Lin SC; Yen HJ; Chen YW; Lee HL; Yang TF
Adv Exp Med Biol; 2023; 1405():421-455. PubMed ID: 37452948
[TBL] [Abstract][Full Text] [Related]
6. [Evolving Exploration of the Pathogenesis of CNS Germ Cell Tumors with Regard to Precision Medicine].
Takami H; Takayanagi S; Tanaka S; Saito N
No Shinkei Geka; 2022 Jan; 50(1):39-50. PubMed ID: 35169085
[TBL] [Abstract][Full Text] [Related]
7. Transcriptome and methylome analysis of CNS germ cell tumor finds its cell-of-origin in embryogenesis and reveals shared similarities with testicular counterparts.
Takami H; Elzawahry A; Mamatjan Y; Fukushima S; Fukuoka K; Suzuki T; Yanagisawa T; Matsushita Y; Nakamura T; Satomi K; Tanaka S; Mukasa A; Saito N; Kanamori M; Kumabe T; Tominaga T; Kobayashi K; Nagane M; Iuchi T; Tamura K; Maehara T; Sugiyama K; Yoshimoto K; Sakai K; Nonaka M; Asai A; Yokogami K; Takeshima H; Narita Y; Shibui S; Nakazato Y; Hama N; Totoki Y; Kato M; Shibata T; Nishikawa R; Matsutani M; Ichimura K
Neuro Oncol; 2022 Aug; 24(8):1246-1258. PubMed ID: 35137206
[TBL] [Abstract][Full Text] [Related]
8. Recurrent neomorphic mutations of MTOR in central nervous system and testicular germ cell tumors may be targeted for therapy.
Ichimura K; Fukushima S; Totoki Y; Matsushita Y; Otsuka A; Tomiyama A; Niwa T; Takami H; Nakamura T; Suzuki T; Fukuoka K; Yanagisawa T; Mishima K; Nakazato Y; Hosoda F; Narita Y; Shibui S; Yoshida A; Mukasa A; Saito N; Kumabe T; Kanamori M; Tominaga T; Kobayashi K; Shimizu S; Nagane M; Iuchi T; Mizoguchi M; Yoshimoto K; Tamura K; Maehara T; Sugiyama K; Nakada M; Sakai K; Kanemura Y; Nonaka M; Asai A; Yokogami K; Takeshima H; Kawahara N; Takayama T; Yao M; Kato M; Nakamura H; Hama N; Sakai R; Ushijima T; Matsutani M; Shibata T; Nishikawa R;
Acta Neuropathol; 2016 Jun; 131(6):889-901. PubMed ID: 26956871
[TBL] [Abstract][Full Text] [Related]
9. Distinct patterns of copy number alterations may predict poor outcome in central nervous system germ cell tumors.
Takami H; Satomi K; Fukuoka K; Nakamura T; Tanaka S; Mukasa A; Saito N; Suzuki T; Yanagisawa T; Sugiyama K; Kanamori M; Kumabe T; Tominaga T; Tamura K; Maehara T; Nonaka M; Asai A; Yokogami K; Takeshima H; Iuchi T; Kobayashi K; Yoshimoto K; Sakai K; Nakazato Y; Matsutani M; Nagane M; Nishikawa R; Ichimura K
Sci Rep; 2023 Sep; 13(1):15760. PubMed ID: 37735187
[TBL] [Abstract][Full Text] [Related]
10. Prognostic implications of distinctive imaging characteristics in primary intracranial germ cell tumors: A retrospective analysis.
Wang YF; Yang YL; Yang SH; Peng SS
J Formos Med Assoc; 2024 May; ():. PubMed ID: 38821737
[TBL] [Abstract][Full Text] [Related]
11. Integrated clinical, histopathological, and molecular data analysis of 190 central nervous system germ cell tumors from the iGCT Consortium.
Takami H; Fukuoka K; Fukushima S; Nakamura T; Mukasa A; Saito N; Yanagisawa T; Nakamura H; Sugiyama K; Kanamori M; Tominaga T; Maehara T; Nakada M; Kanemura Y; Asai A; Takeshima H; Hirose Y; Iuchi T; Nagane M; Yoshimoto K; Matsumura A; Kurozumi K; Nakase H; Sakai K; Tokuyama T; Shibui S; Nakazato Y; Narita Y; Nishikawa R; Matsutani M; Ichimura K
Neuro Oncol; 2019 Dec; 21(12):1565-1577. PubMed ID: 31420671
[TBL] [Abstract][Full Text] [Related]
12. Advances in Molecular Profiling and Developing Clinical Trials of CNS Germ Cell Tumors: Present and Future Directions.
Takami H
Curr Oncol Rep; 2022 Jan; 24(1):105-112. PubMed ID: 35059994
[TBL] [Abstract][Full Text] [Related]
13. Primary Central Nervous System Germ Cell Tumors: A Review and Update.
Fetcko K; Dey M
Med Res Arch; 2018 Mar; 6(3):. PubMed ID: 30271875
[TBL] [Abstract][Full Text] [Related]
14. Histologically confirmed pineal tumors and other germ cell tumors of the brain.
Schild SE; Scheithauer BW; Haddock MG; Wong WW; Lyons MK; Marks LB; Norman MG; Burger PC
Cancer; 1996 Dec; 78(12):2564-71. PubMed ID: 8952565
[TBL] [Abstract][Full Text] [Related]
15. Multi-institutional analysis of central nervous system germ cell tumors in patients with Down syndrome.
Harris MK; Graham RT; Cappellano AM; Margol AS; Michaiel G; Crawford JR; Ioakeim-Ioannidou M; Stanek JR; Liu KX; MacDonald SM; Abdelbaki MS
Pediatr Blood Cancer; 2022 Oct; 69(10):e29830. PubMed ID: 35686831
[TBL] [Abstract][Full Text] [Related]
16. Pediatric central nervous system germ cell tumors: a review.
EchevarrÃa ME; Fangusaro J; Goldman S
Oncologist; 2008 Jun; 13(6):690-9. PubMed ID: 18586924
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid ctDNA and metabolites are informative biomarkers for the evaluation of CNS germ cell tumors.
Takayasu T; Shah M; Dono A; Yan Y; Borkar R; Putluri N; Zhu JJ; Hama S; Yamasaki F; Tahara H; Sugiyama K; Kurisu K; Esquenazi Y; Ballester LY
Sci Rep; 2020 Aug; 10(1):14326. PubMed ID: 32868820
[TBL] [Abstract][Full Text] [Related]
18. A Novel Germline
Yue X; Liu B; Han T; Luo N; Lu G; Guo D; Bu F; Wang G
Front Oncol; 2022; 12():835220. PubMed ID: 35651799
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of intracranial non-germinomatous germ cell tumors: a retrospective Asian multinational study on treatment strategies and prognostic factors.
Hong KT; Han JW; Fuji H; Byun HK; Koh KN; Wong RX; Lee HL; Yoon HI; Lee JH; Phi JH; Kim SK; Kim DS; Lyu CJ; Choi JY; Kang HJ; Chen YW; Lee YY; Im HJ; Ra YS; Do Ahn S; Low SYY; Looi WS; Park HJ; Suh YG; Suh CO; Wang KC; Tan EEK; Wong TT; Kim JY
J Neurooncol; 2022 Oct; 160(1):41-53. PubMed ID: 36045266
[TBL] [Abstract][Full Text] [Related]
20. MRI features of pediatric intracranial germ cell tumor subtypes.
Wu CC; Guo WY; Chang FC; Luo CB; Lee HJ; Chen YW; Lee YY; Wong TT
J Neurooncol; 2017 Aug; 134(1):221-230. PubMed ID: 28551848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]